Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8+ T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP)

被引:213
作者
Yamano, Y
Nagai, M
Brennan, M
Mora, CA
Soldan, SS
Tomaru, U
Takenouchi, N
Izumo, S
Osame, M
Jacobson, S
机构
[1] NINCDS, NIH, NIB, Viral Immunol Sect, Bethesda, MD 20892 USA
[2] Kagoshima Univ, Fac Med, Ctr Chron Viral Dis, Kagoshima 890, Japan
[3] Kagoshima Univ, Fac Med, Dept Internal Med 3, Kagoshima 890, Japan
关键词
D O I
10.1182/blood.V99.1.88
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate the role of viral expression in individuals infected with human T-cell lymphotropic virus type 1 (HTLV-1), a real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) of HTLV-1 tax messenger RNA (mRNA) using ABI Prism 7700 Sequence Detection System was developed. Using this system, the HTLV-1 tax mRNA load was compared with HTLV-1 proviral DNA load, HTLV-1 Tax protein expression, HTLV-1 Tax-specific CD8(+) T-cell frequency, and disease severity of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). This approach was a sensitive and specific technique for the precise quantification of HTLV-1 tax mRNA. The total amount of HTLV-1 tax mRNA and mRNA expression level in HTLV-1-infected cells (mRNA/DNA ratio) were higher in HAM/TSP patients than in asymptomatic HTLV-1 carriers. The HTLV-1 tax mRNA load correlated with the HTLV-1 proviral DNA load ex vivo, the Tax protein expression in vitro, and the Tax-specific CD8(+) T-cell frequency ex vivo. The HTLV-1 tax mRNA load also correlated with disease severity in HAM/TSP patients. These data suggest that increased HTLV-1 expression plays an important role In the pathogenesis of HAM/TSP, and the HTLV-1 tax mRNA level could be a useful predictor of disease progression In patients with HAW TSP.
引用
收藏
页码:88 / 94
页数:7
相关论文
共 51 条
[1]   Quantification of human T-cell lymphotropic virus type 1 proviral load by quantitative competitive polymerase chain reaction [J].
Albrecht, B ;
Collins, ND ;
Newbound, GC ;
Ratner, L ;
Lairmore, MD .
JOURNAL OF VIROLOGICAL METHODS, 1998, 75 (02) :123-140
[2]  
ALI A, 1992, J NEUROL, V239, P270
[3]   QUANTIFICATION OF HTLV-II PROVIRAL COPIES BY COMPETITIVE POLYMERASE CHAIN-REACTION IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF ITALIAN INJECTING DRUG-USERS, CENTRAL AFRICANS, AND AMERINDIANS [J].
CIMARELLI, A ;
DUCLOS, CA ;
GESSAIN, A ;
CATTANEO, E ;
CASOLI, C ;
BIGLIONE, M ;
MAUCLERE, P ;
BERTAZZONI, U .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 (02) :198-204
[4]   AN HTLV-I VACCINE - WHY, HOW, FOR WHOM [J].
DETHE, G ;
BOMFORD, R .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (05) :381-386
[5]   HIGH HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-1 (HTLV-1) SPECIFIC PRECURSOR CYTOTOXIC T-LYMPHOCYTE FREQUENCIES IN PATIENTS WITH HTLV-1 ASSOCIATED NEUROLOGICAL DISEASE [J].
ELOVAARA, I ;
KOENIG, S ;
BREWAH, AY ;
WOODS, RM ;
LEHKY, T ;
JACOBSON, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (06) :1567-1573
[6]   Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis [J].
Furukawa, Y ;
Yamashita, M ;
Usuku, K ;
Izumo, S ;
Nakagawa, M ;
Osame, M .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (05) :1343-1349
[7]   HUMAN T-CELL LEUKEMIA-VIRUS TYPE-1 (HTLV-1) TAX IS EXPRESSED AT THE SAME LEVEL IN INFECTED-CELLS OF HTLV-1-ASSOCIATED MYELOPATHY OR TROPICAL SPASTIC PARAPARESIS PATIENTS AS IN ASYMPTOMATIC CARRIERS BUT AT A LOWER LEVEL IN ADULT T-CELL LEUKEMIA-CELLS [J].
FURUKAWA, Y ;
OSAME, M ;
KUBOTA, R ;
TARA, M ;
YOSHIDA, M .
BLOOD, 1995, 85 (07) :1865-1870
[8]   CELL-SURFACE PHENOTYPE AND HUMAN T-LYMPHOTROPIC VIRUS TYPE-1 ANTIGEN EXPRESSION IN 12 T-CELL LINES DERIVED FROM PERIPHERAL-BLOOD AND CEREBROSPINAL-FLUID OF WEST-INDIAN, GUYANESE AND AFRICAN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS [J].
GESSAIN, A ;
SAAL, F ;
GIRON, ML ;
LASNERET, J ;
LAGAYE, S ;
GOUT, O ;
DETHE, G ;
SIGAUX, F ;
PERIES, J .
JOURNAL OF GENERAL VIROLOGY, 1990, 71 :333-341
[9]  
GESSAIN A, 1990, BLOOD, V75, P428
[10]  
GESSAIN A, 1985, LANCET, V2, P407